This brand name is authorized in Hong Kong, Japan, Poland
The drug CATALIN contains one active pharmaceutical ingredient (API):
|
1
Pirenoxine
UNII 27L0EP6IZK - PIRENOXINE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01XA | Other ophthalmologicals | S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals |
| S01XA91 | Pirenoxine | S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HK | Department of Health Drug Office | Identifier(s): 01059, 32042 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1319706Q1075, 1319706Q2039 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100013117 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
